HTW renews partnership with the All-Wales Therapeutics and Toxicology Centre
Health Technology Wales and the All-Wales Therapeutics & Toxicology Centre (AWTCC) have renewed their Memorandum of Understanding, pledging to continue supporting each other’s work.
The two organisations have worked in collaboration since 2020, sharing expertise and access to networks of experts.
Both organisations carry out health technology assessment, however AWTTC’s remit is to appraise medicines while HTW focusses on non-medicine health technologies and new ways of working.
Through the partnership they have benefited from two-way peer reviews and quality assurance processes to support their appraisal functions.
AWTTC delivers a portfolio of services in therapeutics and toxicology, including health technology appraisal of medicines. Its staff work on health technology assessments; medicines optimisation, medicines safety and toxicology; and analysing prescribing data.
The organisation has representation on several of Health Technology Wales’ groups, including the Appraisal Panel and Front Door Signposting Group.
Karen Samuels, Head of Health Technology Appraisal, Medicines Management and Programme Director AWTTC, said: “At AWTTC our ethos is to work pro-actively to deliver a range of services which support the best use of medicines to help patients in Wales.
This renewal of the Memorandum of Understanding by AWTTC and HTW is an extension of our robust working relationship and provides an ideal opportunity for us to work collaboratively, which undoubtedly improves quality for Welsh patients.”
HTW Director, Dr Susan Myles, added: “Our partnership with AWTTC has brought important mutual benefits for each organisation, including the opportunity to share knowledge and methodological processes and we look forward to building on this relationship.”